-11%-11%
Availability: In Stock

Handbook of Nuclear Cardiology

Heller Gary V., Hendel Robert C.
ISBN: 9781447129448
ISBN: 9781447129448
Εκδόσεις:
Εκδόσεις

Ημ. Έκδοσης

2013
Σελίδες

221
Μορφή

Έντυπο
Συγγραφείς

Κύριος Συγγραφέας

76,00€(Περιλαμβάνεται ΦΠΑ 6%)

Διαθεσιμότητα: 23-28 ημέρες

Κατηγορία:

Περιγραφή

  • Provides simple, case-based approach to the subject
  • Functions as an adjunct to existing literature
  • As a low-priced, colorful and appealing reference resource it will be popular with a large number of cardiologists internationally

Nuclear cardiology procedures have been a mainstay in non-invasive testing for the diagnosis and risk stratification of coronary artery disease for many years. Although a mature field with a multitude of clinical applications, the advances in agents and imaging procedures have been remarkable and important to document.

Handbook of Nuclear Cardiology: Cardiac SPECT and Cardiac PET reviews the important indications for nuclear cardiology procedures, and provides a description of the procedures themselves, including both SPECT and the newer PET imaging protocols as well as key references. The book emphasizes how noninvasive testing results can be used clinically and the appropriateness of such techniques.

The editors and their contributors present critical clinical information on cardiac SPECT and PET within a concise and logical structure, which will be vital for trainees, practicing physicians, nurses and technologists looking for a brief, up-to-date overview and reference volume for nuclear cardiology.

Περιεχόμενα

Part I Ordering the Test: Nuclear Cardiology Procedures
1 SPECT . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 3
Robert C. Hendel
2 Cardiac Positron Emission Tomography. . . . . . . . . . . . . . . . . . . . . . . . . 7
Justin Lundbye
Part II Patient Selection, Which Patient?
3 Overview of Guidelines and Appropriate Use Criteria . . . . . . . . . . . . 19
Katarina H. Nelson and Robert C. Hendel
4 Assessment of Patients with Suspected Coronary
Artery Disease . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 27
Richard T. Ruffin Jr and Gary V. Heller
5 Evaluation of Patients with Known Coronary
Artery Disease . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 37
Dimitrios Barmpouletos and Gary V. Heller
6 Preoperative Evaluation . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 47
Niberto A. Moreno and Robert C. Hendel
7 The Role of Cardiac Nuclear Imaging in Heart Failure. . . . . . . . . . . . 53
Sanjeev U. Nair and Gary V. Heller
8 Myocardial Perfusion Imaging in Specific Patient Populations. . . . . . . . 65
Raja C. Pullatt and Gary V. Heller
Part III Test Performance: How to Do It
9 Exercise Stress Testing. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 79
Jacqueline V.A. Dawson and Robert C. Hendel

10 Pharmacologic Stress Testing . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 87
Apurva O. Badheka and Robert C. Hendel
11 SPECT Radiopharmaceuticals. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 95
Vikas Tandon, Nadine Gauthier, and Terrence D. Ruddy
12 SPECT Instrumentation . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 103
Jared H. Strydhorst, Ross A. Davies, and R. Glenn Wells
13 PET Radiopharmaceuticals . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 115
Jean N. DaSilva, Ana C. Valadiva, Ilias Mylonas, Tayebeh Hadizad,
Robert A. deKemp, and Rob S.B. Beanlands
14 PET Instrumentation. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 127
Jennifer M. Renaud, Rob S.B. Beanlands, and Robert A. deKemp
15 Radiation Safety. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 139
Gary R. Small, Benjamin J.W. Chow, Rob S.B. Beanlands,
and Renée Hessian
Part IV Test Results: What Do They Mean?
16 Interpretation and Reporting of SPECT Myocardial
Perfusion Imaging . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 151
Robert C. Hendel
17 Diagnosis, Risk Stratification and Management of Ischemic
Heart Disease with Nuclear Cardiology. . . . . . . . . . . . . . . . . . . . . . . . 159
Tanyanan Tanawuttiwat and Robert C. Hendel
Part V Comparative Effectiveness of Nuclear Cardiology
18 Exercise Tolerance Testing . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 173
Amyn Malik and Gary V. Heller
19 Echocardiography . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 179
Melissa J. Tracy and Robert C. Hendel
20 Cardiac Computed Tomography Imaging. . . . . . . . . . . . . . . . . . . . . . 187
Talhat Azemi and Gary V. Heller
21 Cardiac Magnetic Resonance (CMR) Imaging. . . . . . . . . . . . . . . . . . 201
Talhat Azemi and Gary V. Heller
22 Cardiac Catheterization . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 211
Amyn Malik and Gary V. Heller
Index . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 217

Σχετικά προϊόντα